ATE179605T1 - Antireaktive antiasthmatische wirkung von acetylsalicylsäure durch inhalation - Google Patents

Antireaktive antiasthmatische wirkung von acetylsalicylsäure durch inhalation

Info

Publication number
ATE179605T1
ATE179605T1 AT92101977T AT92101977T ATE179605T1 AT E179605 T1 ATE179605 T1 AT E179605T1 AT 92101977 T AT92101977 T AT 92101977T AT 92101977 T AT92101977 T AT 92101977T AT E179605 T1 ATE179605 T1 AT E179605T1
Authority
AT
Austria
Prior art keywords
inhalation
antireactive
salicylic acid
drugs
acetyl salicylic
Prior art date
Application number
AT92101977T
Other languages
English (en)
Inventor
Sebastiano Prof Bianco
Original Assignee
B S D Bio Science Dev Snc Di O
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by B S D Bio Science Dev Snc Di O filed Critical B S D Bio Science Dev Snc Di O
Application granted granted Critical
Publication of ATE179605T1 publication Critical patent/ATE179605T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A61K31/025—Halogenated hydrocarbons carbocyclic
    • A61K31/03—Halogenated hydrocarbons carbocyclic aromatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT92101977T 1991-02-09 1992-02-06 Antireaktive antiasthmatische wirkung von acetylsalicylsäure durch inhalation ATE179605T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP91101818 1991-02-09

Publications (1)

Publication Number Publication Date
ATE179605T1 true ATE179605T1 (de) 1999-05-15

Family

ID=8206393

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92101977T ATE179605T1 (de) 1991-02-09 1992-02-06 Antireaktive antiasthmatische wirkung von acetylsalicylsäure durch inhalation

Country Status (16)

Country Link
US (1) US6051566A (de)
JP (1) JPH0648958A (de)
KR (1) KR920016086A (de)
AT (1) ATE179605T1 (de)
AU (1) AU662509B2 (de)
BR (1) BR9200429A (de)
CA (1) CA2060937A1 (de)
CZ (1) CZ281970B6 (de)
DE (1) DE69229070T2 (de)
HU (1) HUT60917A (de)
IE (1) IE920427A1 (de)
IL (1) IL100896A (de)
MX (1) MX9200571A (de)
NO (1) NO179893C (de)
NZ (1) NZ241542A (de)
ZA (1) ZA92890B (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6946117B1 (en) * 1997-09-29 2005-09-20 Nektar Therapeutics Stabilized preparations for use in nebulizers
US20060165606A1 (en) * 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
DK1280520T4 (en) 2000-05-10 2018-06-25 Novartis Ag Phospholipid based powders for drug delivery
US6613308B2 (en) * 2000-09-19 2003-09-02 Advanced Inhalation Research, Inc. Pulmonary delivery in treating disorders of the central nervous system
US7256184B2 (en) * 2000-10-16 2007-08-14 Rodriguez Victorio C Treatment of aging disorders in humans
NZ529417A (en) * 2001-05-24 2006-11-30 Alexza Pharmaceuticals Inc Delivery of alprazolam, estazolam, midazolam or triazolam through an inhalation route
US7766013B2 (en) 2001-06-05 2010-08-03 Alexza Pharmaceuticals, Inc. Aerosol generating method and device
US7458374B2 (en) 2002-05-13 2008-12-02 Alexza Pharmaceuticals, Inc. Method and apparatus for vaporizing a compound
WO2002094246A2 (en) * 2001-05-24 2002-11-28 Alexza Molecular Delivery Corporation Delivery of nonsteroidal antiinflammatory drugs through an inhalation route
WO2002094242A1 (en) * 2001-05-24 2002-11-28 Alexza Molecular Delivery Corporation Delivery of rizatriptan or zolmitriptan through an inhalation route
US7498019B2 (en) 2001-05-24 2009-03-03 Alexza Pharmaceuticals, Inc. Delivery of compounds for the treatment of headache through an inhalation route
JP2005503425A (ja) 2001-05-24 2005-02-03 アレックザ モレキュラー デリヴァリー コーポレイション 所定の吸入ルートによる薬剤エステルの送出
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
US7645442B2 (en) 2001-05-24 2010-01-12 Alexza Pharmaceuticals, Inc. Rapid-heating drug delivery article and method of use
WO2003041693A1 (en) * 2001-11-09 2003-05-22 Alexza Molecular Delivery Corporation Delivery of diazepam through an inhalation route
EP1450787A4 (de) 2001-11-15 2006-01-25 Galileo Pharmaceuticals Inc Formulierungen und verfahren zur behandlung oder linderung von entzündlichen zuständen
AU2002363947A1 (en) 2001-11-21 2003-07-24 Alexza Molecular Delivery Corporation Delivery of caffeine through an inhalation route
EP1458360B1 (de) * 2001-12-19 2011-05-11 Novartis AG Pulmonale verabreichung von aminoglykosiden
EP1503744A1 (de) 2002-05-13 2005-02-09 Alexza Molecular Delivery Corporation Verabreichung von aminenhaltigen arzneistoffen durch inhalation
US20060193788A1 (en) * 2002-11-26 2006-08-31 Hale Ron L Acute treatment of headache with phenothiazine antipsychotics
US20040101481A1 (en) * 2002-11-26 2004-05-27 Alexza Molecular Delivery Corporation Acute treatment of headache with phenothiazine antipsychotics
CA2507159A1 (en) * 2002-11-26 2004-06-10 Alexza Molecular Delivery Corporation Use of loxapine and amoxapine for the manufacture of a medicament for the treatment of pain
US20040105818A1 (en) 2002-11-26 2004-06-03 Alexza Molecular Delivery Corporation Diuretic aerosols and methods of making and using them
US7550133B2 (en) * 2002-11-26 2009-06-23 Alexza Pharmaceuticals, Inc. Respiratory drug condensation aerosols and methods of making and using them
US7913688B2 (en) 2002-11-27 2011-03-29 Alexza Pharmaceuticals, Inc. Inhalation device for producing a drug aerosol
CA2526478A1 (en) 2003-05-21 2004-12-02 Alexza Pharmaceuticals, Inc. Methods of controlling uniformity of substrate temperature and self-contained heating unit and drug-supply unit employing same
US7540286B2 (en) 2004-06-03 2009-06-02 Alexza Pharmaceuticals, Inc. Multiple dose condensation aerosol devices and methods of forming condensation aerosols
US8455437B2 (en) * 2005-02-04 2013-06-04 The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Method to predict and prevent oxygen-induced inflammatory tissue injury
ITMI20050417A1 (it) * 2005-03-15 2006-09-16 Medestea Res & Production S R L Uso di farmaci anti-infiammatori non steroidei per via inalatoria nella terapia della bronchite acuta e cronica
MX2008010353A (es) * 2006-02-09 2009-03-05 Schering Corp Formulaciones farmaceuticas.
JP5094197B2 (ja) * 2006-04-27 2012-12-12 第一三共ヘルスケア株式会社 杯細胞過形成を抑制するための抗ヒスタミン剤含有医薬組成物
EP2121088B1 (de) 2007-03-09 2016-07-13 Alexza Pharmaceuticals, Inc. Erhitzungseinheit zur verwendung in einer arzneimittelabgabevorrichtung
DE102008004386A1 (de) 2008-01-14 2009-07-23 Activaero Gmbh Verwendung eines Acetylsalicylsäuresalzes zur Behandlung viraler Infektionen
WO2009134917A2 (en) * 2008-04-29 2009-11-05 Wyeth Methods for treating inflammation
KR101704815B1 (ko) * 2009-08-21 2017-02-09 포항공과대학교 산학협력단 Ｉｌ－１７ 매개 염증질환의 치료를 위한 조합 제제 및 이를 이용한 치료 방법
WO2013152044A1 (en) * 2012-04-02 2013-10-10 The Board Of Regents Of The University Of Texas System Use of pc-nsaids to treat and/or prevent pulmonary inflammation
US9757395B2 (en) 2012-12-20 2017-09-12 Otitopic Inc. Dry powder inhaler and methods of use
WO2014178891A1 (en) 2013-04-30 2014-11-06 Otitopic Inc. Dry powder formulations and methods of use
TWI586383B (zh) * 2014-04-18 2017-06-11 林信湧 一種用於治療關節炎之吸入式醫藥組成物及其備製方法
EP3191091B1 (de) 2014-09-12 2020-08-26 Children's Medical Center Corporation Formulierungen einer diätetischen emulsion und verfahren zur verwendung davon
WO2016196401A1 (en) * 2015-05-29 2016-12-08 The Texas A&M University System Antimicrobial and anti-inflammatory compositions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5244899A (en) * 1985-02-04 1993-09-14 G. D. Searle And Co. Azabicycloalkyl and azatricycloalkyl amides used to treat inflammation, allergy, asthma and skin disorders
US4885287A (en) * 1988-08-09 1989-12-05 University Of Kentucky Research Foundation Novel method of administering aspirin and dosage forms containing same

Also Published As

Publication number Publication date
NO920504D0 (no) 1992-02-07
CA2060937A1 (en) 1992-08-10
CZ281970B6 (cs) 1997-04-16
MX9200571A (es) 1992-12-01
KR920016086A (ko) 1992-09-24
NO920504L (no) 1992-08-10
IL100896A0 (en) 1992-11-15
IL100896A (en) 1998-02-22
BR9200429A (pt) 1992-10-13
CS35292A3 (en) 1992-08-12
NO179893C (no) 1997-01-08
IE920427A1 (en) 1992-08-12
NZ241542A (en) 1996-05-28
DE69229070D1 (de) 1999-06-10
HUT60917A (en) 1992-11-30
AU1077292A (en) 1992-08-13
US6051566A (en) 2000-04-18
NO179893B (no) 1996-09-30
ZA92890B (en) 1992-12-30
AU662509B2 (en) 1995-09-07
JPH0648958A (ja) 1994-02-22
DE69229070T2 (de) 1999-11-18
HU9200389D0 (en) 1992-04-28

Similar Documents

Publication Publication Date Title
ATE179605T1 (de) Antireaktive antiasthmatische wirkung von acetylsalicylsäure durch inhalation
TR199500856A2 (tr) Nefesle ice cekilerek alinan farmasötik bilesim.
ES2162865T3 (es) Composiciones para inhalacion.
NO305537B1 (no) Farmas°ytisk preparat inneholdene et definert lipidsystem, og anvendelse av lipidsystemet
RU94022269A (ru) Состав аэрозоля, находящийся под давлением
DE3581819D1 (de) Pyridazinamine wirksam gegen viren.
SE8305485L (sv) Galeniska kompositioner innefattande kalcitonin och deras anvendning
IE862554L (en) Pharmaceutical compositions
IT1256697B (it) Medicamenti per trattare condizioni infiammatorie o per analgesia.
ZA92891B (en) Potentiation of the antireactive-antiasthmatic effect of inhaled loop diuretics by inhaled non-steroidal anti-inflammatory drugs
EP0919229A3 (de) Antireaktiver und antiasthmatischer Aktivität von inhalierte nichtsteroidale Entzündungshemmer
PT805157E (pt) Derivados do indole e sua utilizacao medicinal
KR910016327A (ko) 호중구에 의한 엘라스타제 방출 저해제로서의 테니댑의 용도
GB1294681A (en) Novel bis-thiachromonyl compounds their preparation and use
IT8948578A0 (it) Impiego di farmaci anti-infiammatori non steroidei in generale ed in particolare l'acido tiaprofenico, comunemente chiamati fans, in soluzione per applicazione topica sotto forma di spray, realizzato connebulizzatore senza uso di propellenti gassosi.
ATE181828T1 (de) Oral anzuwendendes arzneimittel bestehend aus ibuprofen
IT8348395A0 (it) Composizioni farmaceutiche a basedi solfonammidi e loro impiego per combattere l'obesita'
JPS57114518A (en) Hypotensive agent
ITFI920029V0 (it) " inalatore per addurre aria da inspirare, per impiego in presenza diatmosfere nocive "
JPS55133313A (en) Cholesterol-lowering agent
RU93002216A (ru) Ингалятор

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties